{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:11:51Z","timestamp":1695107511086},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1097\/mph.0000000000001086","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T15:03:56Z","timestamp":1518015836000},"page":"251-252","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Toxicity of Fifth-line Nivolumab in a 15-Year-Old Girl With Metastatic Juvenile Renal Cell Carcinoma"],"prefix":"10.1097","volume":"40","author":[{"given":"Tasnime","family":"Akbaraly","sequence":"first","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Saguintaah","sequence":"additional","affiliation":[{"name":"Pediatric Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Topart","sequence":"additional","affiliation":[{"name":"Medical Oncology, University Hospital of Montpellier, Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.juro.2010.08.092","article-title":"Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors","volume":"85","author":"Malouf","year":"2011","journal-title":"J Urol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","article-title":"Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network G","volume":"21","author":"Malouf","year":"2010","journal-title":"Ann Oncol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2217\/imt.15.65","article-title":"Strategies for combining immunotherapy with radiation for anticancer therapy","volume":"7","author":"Seyedin","year":"2015","journal-title":"Immunotherapy"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:12:16Z","timestamp":1695010336000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001086","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}